What was corrected and how
A subsequent correction by the company to the contents of an already published filing.
Notice Regarding the Simplified Share Exchange to Make 株式会社グランドルーフ a Wholly Owned Subsidiary
5. Overview of the Parties to This Share Exchange: ⑨ Number of Employees; ⑩ Major Customers; ⑫ Major Shareholders and Ownership Ratios; and ⑭ Performance and Financial Position for the Most Recent 3 Years
Number of employees 25 / Key Business Partners パラマウントベッド株式会社, 富士フイルム, メディカル株式会社 and UNICHARM CORPORATION / Major shareholders and shareholding ratios 20 individuals / Net assets for the fiscal year ended October 2024 ¥35 million / Total assets for the fiscal year ended October 2024 ¥247 million / Net assets per share for the fiscal year ended October 2024 ¥35,000.00 / Net sales for the fiscal year ended October 2024 ¥900 million / Operating income for the fiscal year ended October 2024 ¥100 million / Ordinary income for the fiscal year ended October 2024 ¥115 million / Net income for the fiscal year ended October 2024 ¥115 million
Number of employees 2 / Key Business Partners パラマウントベッド株式会社, 富士フイルム and メディカル株式会社 / Major shareholders and shareholding ratios Tasaka Daisaku (田坂 大作) 32.0%, Imamura Go (今村 豪) 21.0%, Imamura Riku (今村 陸) 5.0%, Imamura Kai (今村 海) 5.0%, Imamura Sora (今村 空) 5.0%, Ono Yohei (小野 洋平) 5.0%, Shimoyoshi Kota (下吉 凰太) 5.0%, Shimoyoshi Nao (下吉 菜央) 5.0%, Sugiyama Ryota (杉山 亮太) 5.0%, Yasui Hirotomo (安井 浩倫) 5.0%, Utsunomiya Yuki (宇都宮 由生) 2.0%, Tasaka Masaki (田坂 将貴) 2.0%, Fujisawa Marie (藤澤 麻里衣) 2.0%, Inada Yoshinori (稲田 義範) 1.0% / Net assets for the fiscal year ended October 2024 ¥41 million / Total assets for the fiscal year ended October 2024 ¥267 million / Net assets per share for the fiscal year ended October 2024 ¥41,532.20 / Net sales for the fiscal year ended October 2024 ¥993 million / Operating income for the fiscal year ended October 2024 ¥69 million / Ordinary income for the fiscal year ended October 2024 ¥49 million / Net income for the fiscal year ended October 2024 ¥54 million
The independent investigation committee's final investigation report revealed that, under the director responsible for administration at the time, disclosures regarding the shareholder composition, number of employees, major customers and performance differed from the actual facts.
| Item | Details |
|---|---|
| Disclosure subject to correction | Notice Regarding the Simplified Share Exchange to Make 株式会社グランドルーフ a Wholly Owned Subsidiary |
| Original disclosure date | 20 February 2025 |
| Location of correction | 5. Overview of the Parties to This Share Exchange: ⑨ Number of Employees; ⑩ Major Customers; ⑫ Major Shareholders and Ownership Ratios; and ⑭ Performance and Financial Position for the Most Recent 3 Years |
| Details of correction | Number of employees 25 / Key Business Partners パラマウントベッド株式会社, 富士フイルム, メディカル株式会社 and UNICHARM CORPORATION / Major shareholders and shareholding ratios 20 individuals / Net assets for the fiscal year ended October 2024 ¥35 million / Total assets for the fiscal year ended October 2024 ¥247 million / Net assets per share for the fiscal year ended October 2024 ¥35,000.00 / Net sales for the fiscal year ended October 2024 ¥900 million / Operating income for the fiscal year ended October 2024 ¥100 million / Ordinary income for the fiscal year ended October 2024 ¥115 million / Net income for the fiscal year ended October 2024 ¥115 million → Number of employees 2 / Key Business Partners パラマウントベッド株式会社, 富士フイルム and メディカル株式会社 / Major shareholders and shareholding ratios Tasaka Daisaku (田坂 大作) 32.0%, Imamura Go (今村 豪) 21.0%, Imamura Riku (今村 陸) 5.0%, Imamura Kai (今村 海) 5.0%, Imamura Sora (今村 空) 5.0%, Ono Yohei (小野 洋平) 5.0%, Shimoyoshi Kota (下吉 凰太) 5.0%, Shimoyoshi Nao (下吉 菜央) 5.0%, Sugiyama Ryota (杉山 亮太) 5.0%, Yasui Hirotomo (安井 浩倫) 5.0%, Utsunomiya Yuki (宇都宮 由生) 2.0%, Tasaka Masaki (田坂 将貴) 2.0%, Fujisawa Marie (藤澤 麻里衣) 2.0%, Inada Yoshinori (稲田 義範) 1.0% / Net assets for the fiscal year ended October 2024 ¥41 million / Total assets for the fiscal year ended October 2024 ¥267 million / Net assets per share for the fiscal year ended October 2024 ¥41,532.20 / Net sales for the fiscal year ended October 2024 ¥993 million / Operating income for the fiscal year ended October 2024 ¥69 million / Ordinary income for the fiscal year ended October 2024 ¥49 million / Net income for the fiscal year ended October 2024 ¥54 million |
| Reason for correction | The independent investigation committee's final investigation report revealed that, under the director responsible for administration at the time, disclosures regarding the shareholder composition, number of employees, major customers and performance differed from the actual facts. |
Items this document does not state (1)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The independent investigation committee's final investigation report revealed that, under the director responsible for administration at the time, disclosures regarding the shareholder composition, number of employees, major customers and performance differed from the actual facts.